Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at http://www.fivestarequities.com/ and get exclusive access to our numerous stock reports.
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) shares spiked 10.18 percent to close at $63.05 a share Monday. The stock traded between $56.72 and $63.84 on volume of 1.49 million shares traded. On Monday, the company released positive interim results from its Phase I clinical trial of ALN-TTRsc, a treatment for TTR-mediated amyloidosis. Shares of Alnylam Pharmaceuticals have gained approximately 245.0 percent year-to-date.
Get more information on Alnylam Pharmaceuticals and free access to the in-depth equity report at:
Celldex Therapeutics, Inc. (NASDAQ: CLDX) shares surged 12.85 percent to close at $32.68 a share Monday. The stock traded between $29.41 and $32.90 volume of 6.56 million shares traded. Leerink Swann has raised its price target on the company to $45.00 from $28.00. Shares of Celldex Therapeutics have gained nearly 390.0 percent year-to-date.
Get more information on Celldex Therapeutics and free access to the in-depth equity report at:
Cooper Tire & Rubber Co. (NYSE: CTB) shares declined 6.76 percent to close at $28.85 a share Monday. The stock traded between $28.76 and $30.89 on volume of 3.34 million shares traded. Stockholders are scheduled to vote on September 30th on the previously announced merger with a subsidiary of Apollo Tyres Ltd. Shares of Cooper Tire & Rubber have fallen approximately 13.0 percent year-to-date.
Get more information on Cooper Tire & Rubber and free access to the in-depth equity report at:
US Airways Group Inc. (NYSE: LCC) shares declined 0.16 percent to close at $18.86 a share Monday. The stock traded between $18.54 and $19.00 on volume of 3.35 million shares traded. Standard & Poor's have upgraded the company’s credit rating to "B'' from "B-." Shares of US Airways Group have gained approximately 40.0 percent year-to-date.
Get more information on US Airways Group and free access to the in-depth equity report at:
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.
Five Star Equities
Leave a comment...